We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+1.13%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$10.4B
AUM Growth
-$279M
(-2.6%)
Cap. Flow
-$218M
Cap. Flow
% of AUM
-2.1%
Top 10 Holdings %
Top 10 Hldgs %
17.29%
Holding
1,364
New
413
Increased
268
Reduced
302
Closed
358
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$105M |
| 2 |
EMC
EMC CORPORATION
EMC
|
+$103M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$97.6M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$77.4M |
| 5 |
Humana
HUM
|
+$71.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$125M |
| 2 |
Perrigo
PRGO
|
+$103M |
| 3 |
AGN
Allergan plc
AGN
|
+$99.6M |
| 4 |
Pfizer
PFE
|
+$90M |
| 5 |
Viatris
VTRS
|
+$88.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 15.63% |
| 2 | Healthcare | 15.57% |
| 3 | Communication Services | 13.26% |
| 4 | Technology | 11.56% |
| 5 | Financials | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
YHOO
201
DELISTED
Yahoo Inc
YHOO
| $11.1M | 0.11% |
300,443
-221,825
| -42% | -$6.95M |
|
202
AMC Global Media
AMCX
$430M
| $11M | 0.11% |
169,356
+163,315
| +2,703% | +$11.2M |
|
203
Allison Transmission
ALSN
$10.1B
| $10.7M | 0.1% |
396,205
+102,476
| +35% | +$2.49M |
|
204
Leggett & Platt
LEG
$1.52B
| $10.5M | 0.1% |
+216,846
| New | +$9.4M |
|
205
Salesforce
CRM
$134B
| $10.5M | 0.1% |
141,826
-168,877
| -54% | -$11.6M |
|
206
IDEX
IEX
$16.5B
| $10.4M | 0.1% |
125,260
+37,873
| +43% | +$2.84M |
|
|
IM
207
DELISTED
Ingram Micro
IM
| $10.3M | 0.1% |
+287,161
| New | +$9.18M |
|
208
Hasbro
HAS
$12.6B
| $10.3M | 0.1% |
128,268
+108,036
| +534% | +$8.03M |
|
209
Strategy Inc
MSTR
$33.5B
| $10.1M | 0.1% |
562,580
+434,760
| +340% | +$7.04M |
|
210
Insperity
NSP
$1.85B
| $10.1M | 0.1% |
390,758
+233,600
| +149% | +$5.5M |
|
211
DHT Holdings
DHT
$2.97B
| $9.91M | 0.1% |
1,719,893
+1,104,134
| +179% | +$6.57M |
|
212
Alkermes
ALKS
$8.82B
| $9.87M | 0.1% |
288,682
+209,803
| +266% | +$8.29M |
|
213
Molson Coors Class B
TAP
$7.68B
| $9.81M | 0.09% |
102,027
+13,621
| +15% | +$1.22M |
|
214
Liberty Broadband Class C
LBRDK
$4.15B
| $9.79M | 0.09% |
169,030
+152,522
| +924% | +$7.67M |
|
215
Honeywell
HON
$77.1B
| $9.78M | 0.09% |
97,102
-425,167
| -81% | -$39.8M |
|
216
Marriott International
MAR
$98.7B
| $9.66M | 0.09% |
135,719
-391,662
| -74% | -$25.6M |
|
217
Gildan
GIL
$9.25B
| $9.65M | 0.09% |
+316,425
| New | +$8.4M |
|
218
DuPont de Nemours
DD
$18.6B
| $9.51M | 0.09% |
73,806
-102,944
| -58% | -$12.3M |
|
|
CPE
219
DELISTED
Callon Petroleum Company
CPE
| $9.4M | 0.09% |
106,172
+88,599
| +504% | +$6.16M |
|
220
Amdocs
DOX
$5.53B
| $9.29M | 0.09% |
153,792
+148,567
| +2,843% | +$8.32M |
|
|
HRC
221
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $9.23M | 0.09% |
183,470
+148,630
| +427% | +$7.02M |
|
222
Integer Holdings
ITGR
$3.35B
| $9.19M | 0.09% |
257,911
+212,371
| +466% | +$7.48M |
|
223
Eagle Materials
EXP
$6.6B
| $9.15M | 0.09% |
130,484
-70,544
| -35% | -$4.11M |
|
224
A.O. Smith
AOS
$8.38B
| $9.12M | 0.09% |
+239,018
| New | +$8.36M |
|
225
Willis Towers Watson
WTW
$27.9B
| $9.09M | 0.09% |
+76,618
| New | +$8.82M |
|
Similar funds
Marshall Wace's Q1 2016 Portfolio in Review
As of Q1 2016, Marshall Wace held 1,364 positions worth $10.4B, down 2.6% from $10.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Marshall Wace's Q1 2016 filing shows 413 new, 268 increased, 302 reduced and 358 closed positions. Its largest new stake was iShares MSCI Emerging Markets ETF: 3,149,620 shares worth $108M. The largest sale was Bristol-Myers Squibb, an estimated $125M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 12% a quarter earlier, followed by Healthcare and Communication Services.
- Marshall Wace's largest Q1 2016 buy was iShares MSCI Emerging Markets ETF: 3,149,620 shares worth $108M.
- Marshall Wace added most to Adobe in Q1 2016, an estimated $105M increase.
- Marshall Wace's biggest Q1 2016 reduction was Bristol-Myers Squibb, cutting an estimated $125M.
- Marshall Wace fully exited Perrigo in Q1 2016, selling an estimated $103M.
- Marshall Wace's ten largest holdings make up 17% of its $10.4B portfolio in Q1 2016.
- Marshall Wace opened 413 new positions and closed 358 in Q1 2016.
- Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $10.4B.
Based on Marshall Wace's 13F filing for Q1 2016, filed 13 May 2016.